Skip to main content

Table 1 Baseline characteristics of study participants

From: Non-invasive evaluation of pulmonary arterial blood flow and wall shear stress in pulmonary arterial hypertension with 3D phase contrast magnetic resonance imaging

  Healthy volunteers PAH patients p value
Number, n 6 9  
Age, years 45.8 ± 8.9 41.8 ± 14.7 0.558
Gender, n (male/female) 4/2 1/8 0.089
Height, cm 163.2 ± 10.7 157.7 ± 5.8 0.288
Body weight, kg 60.4 ± 11.1 53.2 ± 6.4 0.234
Body mass index, kg/m2 22.0 ± 2.5 21.4 ± 2.0 0.635
Body surface area, m2 1.63 ± 0.20 1.52 ± 0.11 0.209
IPAH/APAH, n N/A 5/4  
PDE-5 inhibitors, n (%) N/A 8 (88.9)  
Endothelin receptor antagonists, n (%) N/A 8 (88.9)  
Prostanoids, n (%) N/A 5 (55.6)  
  1. Data are expressed as n (%) or mean ± standard deviation
  2. PAH pulmonary arterial hypertension, IPAH idiopathic pulmonary arterial hypertension, APAH associated pulmonary arterial hypertension, PDE-5 inhibitors phosphodiesterase 5 inhibitors, N/A not available